Brief: Sunshine BiopharmaGot Nasdaq Letter That Based On Review Of Co's Public Filings,Supporting Materials Submitted, Determined To Delist Co's Securities

Sunshine Biopharma

07/06/2024 21:21

June 7 (Reuters) - Sunshine Biopharma Inc  SBFM.O :
    * SUNSHINE BIOPHARMA:GOT NASDAQ LETTER THAT BASED ON REVIEW
OF
CO'S PUBLIC FILINGS,SUPPORTING MATERIALS SUBMITTED, DETERMINED
TO DELIST CO'S SECURITIES

Further company coverage:  SBFM.O 

 ((Reuters.Briefs@thomsonreuters.com;))